Standout Papers

APOBEC3B is an enzymatic ... 2013 2026 2017 2021 2013 200 400 600
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation benchmark for papers published in the same subfield and year, or reaches the top citation threshold in at least one of its specific research topics.

  1. APOBEC3B is an enzymatic source of mutation in breast cancer
    2013 634 citations Michael B. Burns, Lela Lackey et al. Nature profile →

Immediate Impact

5 by Nobel laureates 34 from Science/Nature 67 hit
Sub-graph 1 of 21

Citing Papers

NBS1 lactylation is required for efficient DNA repair and chemotherapy resistance
2024 HitNature
CRISPR technology: A decade of genome editing is only the beginning
2023 HitScienceNobel
11 intermediate papers

Works of Allison M. Land being referenced

APOBEC3B is an enzymatic source of mutation in breast cancer
2013 HitNature
Methylcytosine and Normal Cytosine Deamination by the Foreign DNA Restriction Enzyme APOBEC3A
2012
and 1 more

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Allison M. Land 749 329 286 243 215 16 1.3k
Tobias Paprotka 455 0.6× 90 0.3× 197 0.7× 130 0.5× 134 0.6× 20 1.1k
Liesl Nottingham 518 0.7× 221 0.7× 159 0.6× 208 0.9× 217 1.0× 20 1.2k
Matthew T. Miller 864 1.2× 139 0.4× 74 0.3× 277 1.1× 80 0.4× 21 1.5k
Barbara Maschera 491 0.7× 525 1.6× 283 1.0× 206 0.8× 113 0.5× 20 1.7k
Frédéric De Bels 508 0.7× 245 0.7× 59 0.2× 226 0.9× 109 0.5× 29 1.2k
C A Richards 811 1.1× 234 0.7× 41 0.1× 430 1.8× 326 1.5× 18 1.8k
Caryn N. Kim 787 1.1× 187 0.6× 96 0.3× 233 1.0× 193 0.9× 12 1.3k
Olle Karlström 1.1k 1.5× 53 0.2× 138 0.5× 178 0.7× 163 0.8× 33 1.6k
Richard R. Gontarek 849 1.1× 57 0.2× 117 0.4× 108 0.4× 254 1.2× 25 1.3k
André A. Pilon 672 0.9× 485 1.5× 55 0.2× 152 0.6× 223 1.0× 11 1.1k

All Works

Loading papers...

Rankless by CCL
2026